Featured Research

from universities, journals, and other organizations

PET/CT Should Be 'First-step' Test For Patients With Crohn's Disease

Date:
June 5, 2007
Source:
Society of Nuclear Medicine
Summary:
The molecular imaging power of PET/CT is invaluable in noninvasively monitoring Crohn's disease -- a chronic inflammatory disease of the gastrointestinal tract that mainly affects young people, according to a new study.

The molecular imaging power of PET/CT is invaluable in noninvasively monitoring Crohn's disease--a chronic inflammatory disease of the gastrointestinal tract that mainly affects young people, according to a study released by Belgian scientists at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals.

Related Articles


"Our study is the first one demonstrating the value of PET/CT in Crohn's disease," said Roland Hustinx, head of the nuclear medicine division at the University Hospital of Liθge and professor of nuclear medicine at the University of Liθge. "PET/CT (positron emission tomography/computed tomography) imaging--with the radiotracer fluorodeoxyglucose or FDG--could be used as a first-step test in patients with clinical or biological signs suggesting active disease," he noted. "PET/CT can answer the major question: What is the activity of the disease"" explained Hustinx.

Crohn's disease, an inflammatory bowel disease (IBD) that can affect the digestive system, has no medical cure, and its causes are unknown, explained Hustinx. Once the disease begins, it can fluctuate between periods of inactivity (remission) and activity (relapse). During relapses, symptoms--varying in nature, frequency and intensity--include abdominal pain, diarrhea and worsening general physical condition. Estimates indicate that up to 2 million people in this country could be affected by Crohn's and related diseases. IBD most commonly begins during adolescence and early adulthood.

"The clinical course of the disease is characterized by a succession of periods of clinical relapses and remissions," said Hustinx. "Its diagnosis relies on clinical and biological signs (markers of inflammation in the blood) as well as direct examination of the bowel using ileocolonoscopy, an endoscopic examination of the large bowel, where the last part of the small bowel (ileum) is also examined," added Hustinx, who indicated that prevalence of the disease is increasing.

"Endoscopic evaluation--a diagnostic medical procedure in which a small, flexible tube with a light and lens is inserted into the body to assess the interior surfaces of an organ--is the gold standard to answer, 'What is the activity of this disease"'" said Hustinx. The answer to this question will decide whether the clinician prescribes a treatment that is likely to be effective but also very costly and associated with side effects. "Ileocolonoscopy is invasive, unpleasant for the patient, sometimes incomplete due to unreachable segments and can only assess mucosal lesions, while the disease may sometimes affect deeper parts of the bowel wall," he indicated.

"The big advantage of PET/CT is that it is noninvasive, simple, fast and without any side effects. There was no preparation for the patients, except that they fasted for six hours. Each study took less than 20 minutes," said Hustinx. "If the PET/CT is positive, the doctor should confirm the results using endoscopy. If the PET/CT is negative, there would be no need for the endoscopy--given the high negative predictive value of the technique," he added.

"In our study, all bowel areas that showed severe endoscopic lesions were correctly identified by PET/CT. There was not a single case in which the ileocolonoscopy showed severe lesions and PET/CT showed a normal metabolic activity," said Hustinx. "Conversely, this means that when the PET/CT is negative--no matter how important the clinical symptoms are--the disease is not active," he added. "PET/CT has, therefore, the potential to deeply modify the exploration algorithm of patients with Crohn's, reducing the number of endoscopic examinations and allowing a better, noninvasive monitoring of the disease's activity," he indicated.

PET/CT molecular imaging--with radioactive drugs such as FDG--enables the collection of both biological and anatomical information during a single exam, with PET picking up metabolic signals of body cells and tissues and CT offering a detailed map of internal anatomy.

"Our results must be confirmed by other investigators on a larger scale," said Hustinx, indicating that his team is currently conducting a study evaluating the capacity of PET/CT to assess early on the response of the disease to "biological treatments." Treatment has been significantly improved over the past few years with the development of biological treatments, which have shown potential for obtaining mucosal healing in Crohn's disease, noted Hustinx. "This mucosal healing has been associated with higher sustained quality of life, lower rate of hospitalization and lower need for surgery. A sustained clinical remission--and a control of intestinal lesion--has become the target of new treatment strategies," he said.

Scientific Paper 219: R. Hustinx, G. Ancion, Nuclear Medicine; A. Collard, J. Belaiche and E. Louis, Gastroenterology; and V. Spote, Radiology, all at CHU (Centre Hospitalier Universitaire), Liθge, Belgium, "Assessment of Crohn's Disease Intestinal Lesions With FDG PET/CT: A Prospective Correlation With Endoscopy," SNM's 54th Annual Meeting, June 2--6, 2007.


Story Source:

The above story is based on materials provided by Society of Nuclear Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Society of Nuclear Medicine. "PET/CT Should Be 'First-step' Test For Patients With Crohn's Disease." ScienceDaily. ScienceDaily, 5 June 2007. <www.sciencedaily.com/releases/2007/06/070604155841.htm>.
Society of Nuclear Medicine. (2007, June 5). PET/CT Should Be 'First-step' Test For Patients With Crohn's Disease. ScienceDaily. Retrieved November 20, 2014 from www.sciencedaily.com/releases/2007/06/070604155841.htm
Society of Nuclear Medicine. "PET/CT Should Be 'First-step' Test For Patients With Crohn's Disease." ScienceDaily. www.sciencedaily.com/releases/2007/06/070604155841.htm (accessed November 20, 2014).

Share This


More From ScienceDaily



More Matter & Energy News

Thursday, November 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Latest Minivan Crash Tests Aren't Pretty

Latest Minivan Crash Tests Aren't Pretty

Newsy (Nov. 20, 2014) — Five minivans were put to the test in head-on crash simulations by the Insurance Institute for Highway Safety. Video provided by Newsy
Powered by NewsLook.com
Takata Offers "sincerest Condolences" To Victims of Malfunctioning Airbag

Takata Offers "sincerest Condolences" To Victims of Malfunctioning Airbag

Reuters - US Online Video (Nov. 20, 2014) — U.S. Congress hears from a victim and company officials as it holds a hearing on the safety of Takata airbags after reports of injuries. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Shape-Shifting Architecture That Responds to Heat

Shape-Shifting Architecture That Responds to Heat

Reuters - Innovations Video Online (Nov. 19, 2014) — Architectural research students in Barcelona showcase a prototype of a shape-shifting building which expands and contracts as heat is applied. Amy Pollock reports. Video provided by Reuters
Powered by NewsLook.com
Flying Aviation Expo 2014: A Weekend to Remember

Flying Aviation Expo 2014: A Weekend to Remember

Flying (Nov. 19, 2014) — Get a taste of all the excitement at the first ever Flying Aviation Expo in Palm Springs, California. Video provided by Flying
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins